MSD's oral HIF-2 alpha inhibitor Welireg has a third FDA approval, becoming the first oral treatment for a rare form of solid tumour that affects around 2,000 people in the US each year. The green ...

Check for the Update Windows 11 has been accessible for some time as an update on compatible Windows 10 systems, so your next step should be to see if it's already available on your PC. In Windows 10, ...

MSD has fleshed out its cardiovascular disease pipeline by licensing an oral Lp(a) inhibitor from China's Jiangsu Hengrui Pharma for $200 million upfront. The deal gives MSD exclusive rights to the ...

About Jochu Technology Co. Ltd. Jochu Technology Co., Ltd. engages in the manufacturing, processing, and trading of optoelectronic components, molds, and precision instruments. Its products include ...